Where does Nirmesh Patel work?

Nirmesh Patel is Founder of Cambridge Cancer Genomics.

What check size does Nirmesh Patel write?

Nirmesh Patel typically writes checks of $1M – $5M.

What companies did Nirmesh Patel found?

Nirmesh Patel founded Cambridge Cancer Genomics.

Where did Nirmesh Patel go to school?

Nirmesh Patel studied at Y Combinator (Batch of S17); King's College London (Doctor of Philosophy (PhD), Oncology and Cancer Biology); Quantic School of Business and Technology (Master of Business Administration - MBA).

Nirmesh Patel

Founder

Founder at Cambridge Cancer Genomics · Former Investor at The Venture Collective

London

Writes $1M – $5M checks · typically $3M

FoundedCambridge Cancer Genomics · YC

Find your path to Nirmesh

10,880 people in our graph can introduce you to Nirmesh.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Justine Clark to introduce you to Nirmesh

You →Justine · together at Capital Enterprise (2021) →Nirmesh

Ask Jamie Chen to introduce you to Nirmesh

You →Jamie · together at The Venture Collective (TVC) →Nirmesh

Ask Sam Okafor to introduce you to Nirmesh

You →Sam · 2 people · together at Forbes →Nirmesh

Your email: the people you already email who know Nirmesh
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Nirmesh
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Nirmesh Patel is a scientist and entrepreneur who completed a PhD in cancer research, with discoveries that were partnered with major pharmaceutical companies. He co-founded a company focused on matching cancer patients to appropriate therapies, which he grew for over five years before its acquisition in 2021. Patel is now an investor at Amino Collective, where he leads investments in biology and deeptech companies at the pre-seed and seed stages.

Founder at Cambridge Cancer Genomics YC S17

Intro paths

Nirmesh went through Y Combinator (Summer 2017) — any YC alum in your network can reach them through the YC community.

→

In turn, Nirmesh can intro founders to Cambridge Cancer Genomics's investors below.

Cambridge Cancer Genomics's investors · 15

AME Cloud VenturesPalo Alto · $1M – $10M checks Amplify PartnersMenlo Park · $500K – $5M checks Endure CapitalAmsterdam FrialeNashville · $100K – $600K checks FundersClubSan Francisco · $290K checks Hack VCPalo Alto · $3M checks Liquid VenturesSan Francisco · $250K – $5M checks MetaplanetTallinn · $500K – $10M checks Pi CampusRome · $55K – $540K checks Refactor CapitalBurlingame · $1M – $2M checks Romulus CapitalBoston · $250K – $10M checks RTLP LLCNew York Soma CapitalSacramento · $100K – $300K checks Vy CapitalDubai Y CombinatorSan Francisco · $500K checks · since 2017

Co-founders at Cambridge Cancer Genomics

John CassidyFounder

Evaline TsaiFounder

Experience

Amino CollectiveInvestorcurrent2024 — present
VALID IncBoard Membercurrent2024 — present
Stealth Autonomous Lab CoBoard Observercurrent2026 — present
Stealth Clinical Trial Simulation CoInvestorcurrent2026 — present
TheoremaInvestorcurrent2026 — present
Lir TherapeuticsBoard Observercurrent2024 — present
Founders at the University of CambridgeAdvisorcurrent2023 — present
Various StartupsInvestorcurrent2017 — present
Unnatural Products Inc.Board Observer2023 — 2024
coding.bioBoard Member2022 — 2024
Orbillion Bio (YC W21)Board Observer2023 — 2024
EntocycleBoard Observer2023 — 2024
Pragma BioBoard Advisor2022 — 2024
The Venture Collective (TVC)Principal2021 — 2024
Capital EnterpriseEntrepreneur In Residence2021 — 2023
Dante GenomicsGeneral Manager2020 — 2021
CCG.ai (acquired by Dante Labs)Co-Founder & Chief Scientific Officer2016 — 2021Greater Cambridge Area
ForbesEuropean 30 Under 302019
King's College LondonPHD Student2013 — 2017
Breakthrough Breast CancerResearch Associate2012 — 2013

Frequently asked questions

Who is Nirmesh Patel?: Nirmesh Patel is a scientist and entrepreneur who completed a PhD in cancer research, with discoveries that were partnered with major pharmaceutical companies. He co-founded a company focused on matching cancer patients to appropriate therapies, which he grew for over five years before its acquisition in 2021. Patel is now an investor at Amino Collective, where he leads investments in biology and deeptech companies at the pre-seed and seed stages.
Where does Nirmesh Patel work?: Nirmesh Patel is Founder of Cambridge Cancer Genomics.
What check size does Nirmesh Patel write?: Nirmesh Patel typically writes checks of $1M – $5M.
What companies did Nirmesh Patel found?: Nirmesh Patel founded Cambridge Cancer Genomics.
Where did Nirmesh Patel go to school?: Nirmesh Patel studied at Y Combinator (Batch of S17); King's College London (Doctor of Philosophy (PhD), Oncology and Cancer Biology); Quantic School of Business and Technology (Master of Business Administration - MBA).